Skip to main content
. Author manuscript; available in PMC: 2014 Mar 12.
Published in final edited form as: Ann Otol Rhinol Laryngol. 2013 Feb;122(2):100–108. doi: 10.1177/000348941312200205

Table 2. Patient demographics.

Total (n = 49) BTX Only (n = 32) BTX and Myotomy (n = 17)
Male 19 (39%) 9 (28%) 10 (58%)
Female 30 (61%) 23 (71%) 7 (41%)
Number deceased 8 (16%) 6 (19%) 2 (12%)
Mean age and range (y) 59 (27-91) 61 (34-91) 54 (27-83)
Feeding tube 7 (14%) 3 (9%) 4 (23%)
Aspiration pneumonia 5 (10%) 2 (6%) 3 (18%)
Prior head and neck irradiation 4 (8%) 3 (9%) 1 (6%)
Prior head and neck surgery 15 (30%) 7 (22%) 8 (47%)
Prior CVA 2 (4%) 0 2 (12%)
History of neurodegenerative disease 24 (49%) 17 (53%) 7 (41%)
Esophageal dysfunction or dysmotility 12 (24%) 9 (28%) 3 (18%)

BTX — botulinum toxin.